Microsoft Word - (提出用)20150713リリース(英文)Press_English.doc


July 13, 2015

Notice Concerning Determination of Details of Issuance of Stock Options (Stock Acquisition Rights)

ONO PHARMACEUTICAL CO., LTD. (Osaka, Japan; President, Representative Director and CEO, Gyo Sagara; "ONO") announced that the pending conditions of Stock Options (Stock Acquisition Rights) resolved at the meeting of Board of Directors held on June 26, 2015 have been determined today as set forth below.
1. Total number of the Stock Acquisition Rights: 29（The number of shares issued per
Stock Acquisition Right is 100.）
2. Amount to be paid for the Stock Acquisition Rights:
1,077,600 yen per Stock Acquisition Right (10,776 yen per share)
3. Allottees and the number of Stock Acquisition Rights:

Allottees

Number

Number of Stock Acquisition Rights

ONO's Directors

(excluding outside directors)

5

29

Contact ONO PHARMACEUTICAL CO., LTD. Corporate Communications public_relations@ono.co.jp
distributed by